Global Epigenetics Market

Epigenetics Comprehensive Study by Type (Enzymes, Kits & Assays, Instruments, Reagents), Application (Oncology, - Solid Tumors, - Liquid Tumors, Non-Oncology, - Inflammatory Diseases, - Metabolic Diseases, - Infectious Diseases, - Cardiovascular Diseases, - Developmental Biology, - Drug Discovery), Epigenetic Modifications (DNA Methylation, Histone Methylation, Histone Acetylation, Large Noncoding RNA, Chromatin Remodelling, Histone Modifications, Non-Coding RNA Mechanisms) Players and Region - Global Market Outlook to 2030

Epigenetics Market by XX Submarkets | Forecast Years 2024-2030  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
About Epigenetics
Epigenetics is the study of heritable changes in gene expression which do not involve changes to the underlying DNA sequence. Epigenetic change is a regular and natural occurrence but it can be influenced by several factors including age, environment, and disease state. Its changes can help determine whether genes are turned on or off and can influence the production of proteins in certain cells, ensuring that only necessary proteins are produced.

AttributesDetails
Study Period2018-2030
Base Year2023
UnitValue (USD N)


Epigenetics is a fragmented market due to the presence of various players. The players are focusing on strategic activities like partnerships, mergers, and acquisitions which will help them to sustain in the market and maintain their competitive edge. Analyst at AMA Research estimates that United States, Switzerland Players will contribute the maximum growth to Global Epigenetics market throughout the forecasted period. Established and emerging Players should take a closer view at their existing organizations and reinvent traditional business and operating models to adapt to the future.

Roche Diagnostics (Switzerland), Thermo Fisher Scientific (United States), Eisai Co. Ltd. (Japan), Novartis AG. (Switzerland), Merck KGaA (Germany), Abcam plc (United Kingdom), Agilent Technologies (United States), Active Motif (United States), QIAGEN (Germany) and Bio-Rad Laboratories Inc. (United States) are some of the key players that are part of study coverage. Additionally, the Players which are also part of the research coverage are PerkinElmer Inc. (United States), New England Biolabs (United States) and Illumina Inc. (United States).

Segmentation Overview
AMA Research has segmented the market of Global Epigenetics market by Type (Enzymes, Kits & Assays, Instruments and Reagents), Application (Oncology, - Solid Tumors, - Liquid Tumors, Non-Oncology, - Inflammatory Diseases, - Metabolic Diseases, - Infectious Diseases, - Cardiovascular Diseases, - Developmental Biology and - Drug Discovery) and Region.



On the basis of geography, the market of Epigenetics has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). If we see Market by Epigenetic Modifications, the sub-segment i.e. DNA Methylation will boost the Epigenetics market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.

Influencing Trend:
Increase In Promoting Funding and Support To R&D and Product Development Exercises Pertaining To Field Of Epigenetics

Market Growth Drivers:
Rising Geriatric Population, Increasing Prevalence of Cancer and Other Chronic Diseases and Presence of Organizations Such As the International Human Epigenome Consortium (IHEC), the National Cancer Institute (NCI), and the National Institute Of Health (NIH) Is Positively Influencing the Growth of the Market

Restraints:
High Cost Structure of the Procedures and the Lack of Fund Is Become Restraint for the Growth of This Market

Opportunities:
Asia-Pacific Possesses High Market Potential Due To Owing High Incidence of Cancer

Market Leaders and their expansionary development strategies
In April 2023, Eisai Co., Ltd. announced that it has entered into an agreement with the National Cancer Center to collaborate on investigator-initiated clinical research for the EZH2 inhibitor tazemetostat hydrobromide based on “Patient-Proposed Healthcare Services” system.
In Mar 2019, Zenith Epigenetics Announced United State FDA Clearance Of Investigational New Drug Application For ZEN-3694 In TNBC Program. Additionally, In Jan 2019, Australian Researcher From The University Of Newcastle And The Hunter Medical Research Institute Have Received Funding For Two Projects That Will Study Unexplored Areas In Multiple Sclerosis On Epigenetics And Fatigue In Australia.


Key Target Audience
Academic Research Institutes, Biotechnology Companies, Biopharmaceutical Companies, Diagnostic Companies and Contract Research Organizations

About Approach
To evaluate and validate the market size various sources including primary and secondary analysis is utilized. AMA Research follows regulatory standards such as NAICS/SIC/ICB/TRCB, to have a better understanding of the market. The market study is conducted on basis of more than 200 companies dealing in the market regional as well as global areas with the purpose to understand the companies positioning regarding the market value, volume, and their market share for regional as well as global.

Further to bring relevance specific to any niche market we set and apply a number of criteria like Geographic Footprints, Regional Segments of Revenue, Operational Centres, etc. The next step is to finalize a team (In-House + Data Agencies) who then starts collecting C & D level executives and profiles, Industry experts, Opinion leaders, etc., and work towards appointment generation.

The primary research is performed by taking the interviews of executives of various companies dealing in the market as well as using the survey reports, research institute, and latest research reports. Meanwhile, the analyst team keeps preparing a set of questionnaires, and after getting the appointee list; the target audience is then tapped and segregated with various mediums and channels that are feasible for making connections that including email communication, telephonic, skype, LinkedIn Group & InMail, Community Forums, Community Forums, open Survey, SurveyMonkey, etc.

Report Objectives / Segmentation Covered

By Type
  • Enzymes
  • Kits & Assays
  • Instruments
  • Reagents
By Application
  • Oncology
  • - Solid Tumors
  • - Liquid Tumors
  • Non-Oncology
  • - Inflammatory Diseases
  • - Metabolic Diseases
  • - Infectious Diseases
  • - Cardiovascular Diseases
  • - Developmental Biology
  • - Drug Discovery
By Epigenetic Modifications
  • DNA Methylation
  • Histone Methylation
  • Histone Acetylation
  • Large Noncoding RNA
  • Chromatin Remodelling
  • Histone Modifications
  • Non-Coding RNA Mechanisms

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Rising Geriatric Population
      • 3.2.2. Increasing Prevalence of Cancer and Other Chronic Diseases
      • 3.2.3. Presence of Organizations Such As the International Human Epigenome Consortium (IHEC), the National Cancer Institute (NCI), and the National Institute Of Health (NIH) Is Positively Influencing the Growth of the Market
    • 3.3. Market Trends
      • 3.3.1. Increase In Promoting Funding and Support To R&D and Product Development Exercises Pertaining To Field Of Epigenetics
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Epigenetics, by Type, Application, Epigenetic Modifications and Region (value and price ) (2018-2023)
    • 5.1. Introduction
    • 5.2. Global Epigenetics (Price)
      • 5.2.1. Global Epigenetics by: Type (Price)
  • 6. Epigenetics: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2023)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Roche Diagnostics (Switzerland)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Thermo Fisher Scientific (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Eisai Co. Ltd. (Japan)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Novartis AG. (Switzerland)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Merck KGaA (Germany)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Abcam plc (United Kingdom)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Agilent Technologies (United States)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Active Motif (United States)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. QIAGEN (Germany)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Bio-Rad Laboratories Inc. (United States)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global Epigenetics Sale, by Type, Application, Epigenetic Modifications and Region (value and price ) (2025-2030)
    • 7.1. Introduction
    • 7.2. Global Epigenetics (Price)
      • 7.2.1. Global Epigenetics by: Type (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Epigenetics: by Type(USD/Units)
  • Table 2. Company Basic Information, Sales Area and Its Competitors
  • Table 3. Company Basic Information, Sales Area and Its Competitors
  • Table 4. Company Basic Information, Sales Area and Its Competitors
  • Table 5. Company Basic Information, Sales Area and Its Competitors
  • Table 6. Company Basic Information, Sales Area and Its Competitors
  • Table 7. Company Basic Information, Sales Area and Its Competitors
  • Table 8. Company Basic Information, Sales Area and Its Competitors
  • Table 9. Company Basic Information, Sales Area and Its Competitors
  • Table 10. Company Basic Information, Sales Area and Its Competitors
  • Table 11. Company Basic Information, Sales Area and Its Competitors
  • Table 12. Epigenetics: by Type(USD/Units)
  • Table 13. Research Programs/Design for This Report
  • Table 14. Key Data Information from Secondary Sources
  • Table 15. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Epigenetics: by Type USD/Units (2018-2023)
  • Figure 5. Global Epigenetics share by Players 2023 (%)
  • Figure 6. Global Epigenetics share by Players (Top 3) 2023(%)
  • Figure 7. Global Epigenetics share by Players (Top 5) 2023(%)
  • Figure 8. BCG Matrix for key Companies
  • Figure 9. Roche Diagnostics (Switzerland) Revenue, Net Income and Gross profit
  • Figure 10. Roche Diagnostics (Switzerland) Revenue: by Geography 2023
  • Figure 11. Thermo Fisher Scientific (United States) Revenue, Net Income and Gross profit
  • Figure 12. Thermo Fisher Scientific (United States) Revenue: by Geography 2023
  • Figure 13. Eisai Co. Ltd. (Japan) Revenue, Net Income and Gross profit
  • Figure 14. Eisai Co. Ltd. (Japan) Revenue: by Geography 2023
  • Figure 15. Novartis AG. (Switzerland) Revenue, Net Income and Gross profit
  • Figure 16. Novartis AG. (Switzerland) Revenue: by Geography 2023
  • Figure 17. Merck KGaA (Germany) Revenue, Net Income and Gross profit
  • Figure 18. Merck KGaA (Germany) Revenue: by Geography 2023
  • Figure 19. Abcam plc (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 20. Abcam plc (United Kingdom) Revenue: by Geography 2023
  • Figure 21. Agilent Technologies (United States) Revenue, Net Income and Gross profit
  • Figure 22. Agilent Technologies (United States) Revenue: by Geography 2023
  • Figure 23. Active Motif (United States) Revenue, Net Income and Gross profit
  • Figure 24. Active Motif (United States) Revenue: by Geography 2023
  • Figure 25. QIAGEN (Germany) Revenue, Net Income and Gross profit
  • Figure 26. QIAGEN (Germany) Revenue: by Geography 2023
  • Figure 27. Bio-Rad Laboratories Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 28. Bio-Rad Laboratories Inc. (United States) Revenue: by Geography 2023
  • Figure 29. Global Epigenetics: by Type USD/Units (2025-2030)
List of companies from research coverage that are profiled in the study
  • Roche Diagnostics (Switzerland)
  • Thermo Fisher Scientific (United States)
  • Eisai Co. Ltd. (Japan)
  • Novartis AG. (Switzerland)
  • Merck KGaA (Germany)
  • Abcam plc (United Kingdom)
  • Agilent Technologies (United States)
  • Active Motif (United States)
  • QIAGEN (Germany)
  • Bio-Rad Laboratories Inc. (United States)
Additional players considered in the study are as follows:
PerkinElmer Inc. (United States) , New England Biolabs (United States) , Illumina Inc. (United States)
Select User Access Type

Key Highlights of Report


Jan 2024 216 Pages 68 Tables Base Year: 2023 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Epigenetics Market Quantitative research analysis
Global Epigenetics Market Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

The standard version of the report profiles players such as Roche Diagnostics (Switzerland), Thermo Fisher Scientific (United States), Eisai Co. Ltd. (Japan), Novartis AG. (Switzerland), Merck KGaA (Germany), Abcam plc (United Kingdom), Agilent Technologies (United States), Active Motif (United States), QIAGEN (Germany) and Bio-Rad Laboratories Inc. (United States) etc.
The Study can be customized subject to feasibility and data availability. Please connect with our sales representative for further information.
"Increase In Promoting Funding and Support To R&D and Product Development Exercises Pertaining To Field Of Epigenetics" is seen as one of major influencing trends for Epigenetics Market during projected period 2023-2030.
The Epigenetics market study includes a random mix of players, including both market leaders and some top growing emerging players. Connect with our sales executive to get a complete company list in our research coverage.

Know More About Global Epigenetics Market Report?

Have a Query? Click Here

Other Related Reports

Dental Services Comprehensive Study by Type (Dental Implants, Orthodontics, Periodontics, Root Canal – Endodontics, Cosmetic Dentistry, Laser Dentistry, Dentures, Oral and Maxillofacial Surgery, Smil...
$ 3450
Microbial Identification Comprehensive Study by Type (Instruments {Automated Microbial Identification Systems,.Mass Spectrometers, PCR, Microarrays, High-power Microscopes, Polystainers, Flow Cytomet...
$ 3750
Human Fibrinogen Comprehensive Study by Fibrinogen Test Results (Normal Results, Abnormal Results), End Users (Congenital Fibrinogen Deficiency, Surgical Procedures), Fibrinogen Deficiency (Afibrino...
$ 3350
Track and Trace Solutions Comprehensive Study by Type (Hardware Systems (Printing & Marking Solutions, Monitoring & Verification Solutions, Labeling Solutions, Others), Software Solution (Plant Manag...
$ 3750
Hydrokinetic Fiber Dressings Comprehensive Study by Wound (Acute wounds, Burns, Surgical & traumatic wounds, Chronic wounds, Venous leg ulcers, Pressure ulcers, Diabetic foot ulcers, Other chronic w...
$ 3800
Disruptive Behavior Disorders Comprehensive Study by Type (Oppositional Defiant Disorder (ODD), Conduct Disorder (CD), Attention Deficit Hyperactivity Disorder (ADHD)), Application (Hospital, Clinic,...
$ 3750